Fiona Bhondoekhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fiona Bhondoekhan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Brandon David Lewis Marshall
Affiliation Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, United States of America
2 shared publications - Alexandria Macmadu
Department of Epidemiology, Brown University School of Public Health, Providence, USA
1 shared publication - Anees Bahji
Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
1 shared publication Benjamin D. Hallowell
Rhode Island Department of Health, 3 Capitol Hill, Providence, RI 02908, USA
1 shared publication- E. Jennifer Edelman
Program in Addiction Medicine, Yale School of Medicine, New Haven, CT
1 shared publication Francesca L. Beaudoin
Brown University School of Public Health, Department of Epidemiology, 121 South Main Street, Providence, RI 02903, USA
1 shared publication
Latest Publications
- Open Access
- 11 August 2023
- Published by Elsevier in Addictive Behaviors Reports
- Vol. 18, 100512
The impact of polysubstance use patterns on engagement of substance use disorder treatment among emergency department patients at high risk of opioid overdose
- 11 August 2023
- Published by Elsevier in Addictive Behaviors Reports
- Vol. 18, 100512
Open AccessThe impact of polysubstance use patterns on engagement of substance use disorder treatment among emergency department patients at high risk of opioid overdose
- Open Access
- 6 May 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (9) , 5649
Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study
Background: The association between cannabis use and HIV-1 RNA (viral load) among people with HIV (PWH) engaged in care is unclear. Methods: We used data collected from 2002 to 2018 on PWH receiving antiretroviral therapy (ART) enrolled in the Veterans Aging Cohort Study. Generalized estimating equations were used to estimate associations between self-reported past-year cannabis use and detectable viral load (≥500 copies/mL), with and without adjustment for demographics, other substance use, and adherence. Results: Among 2515 participants, 97% were male, 66% were Black, the mean age was 50 years, and 33% had detectable HIV viral load at the first study visit. In unadjusted analyses, PWH with any past-year cannabis use had 21% higher odds of a detectable viral load than those with no past-year use (OR = 1.21; 95% CI, 1.07–1.37). However, there was no significant association between cannabis use and viral load after adjustment. Conclusions: Among PWH engaged in care and receiving ART, cannabis use is associated with decreased adherence in unadjusted analyses but does not appear to directly impact viral control. Future studies are needed to understand other potential risks and benefits of cannabis use among PWH.
- 6 May 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (9) , 5649
Open AccessSelf-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study
Background: The association between cannabis use and HIV-1 RNA (viral load) among people with HIV (PWH) engaged in care is unclear. Methods: We used data collected from 2002 to 2018 on PWH receiving antiretroviral therapy (ART) enrolled in the Veterans Aging Cohort Study. Generalized estimating equations were used to estimate associations between self-reported past-year cannabis use and detectable viral load (≥500 copies/mL), with and without adjustment for demographics, other substance use, and adherence. Results: Among 2515 participants, 97% were male, 66% were Black, the mean age was 50 years, and 33% had detectable HIV viral load at the first study visit. In unadjusted analyses, PWH with any past-year cannabis use had 21% higher odds of a detectable viral load than those with no past-year use (OR = 1.21; 95% CI, 1.07–1.37). However, there was no significant association between cannabis use and viral load after adjustment. Conclusions: Among PWH engaged in care and receiving ART, cannabis use is associated with decreased adherence in unadjusted analyses but does not appear to directly impact viral control. Future studies are needed to understand other potential risks and benefits of cannabis use among PWH.